Biological preparations in the nature of artificial DNA sequences for use in biotechnology

financial services, namely providing financial analysis and reports on earnings, dividends, and shareholder value in light of stock-based compensation for companies

Computer Software for performing simulations and calculations in the fields of accounting and financial analysis